Kolexia
Farret Anne Endocrinologie
Farret Anne
Endocrinologie
Amtim
Montpellier, France
120 Activités
53 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Diabète de type 1 Hypoglycémie Diabète Hyperglycémie Diabète de type 2 Stéatose Stéatose hépatique Insulinorésistance Complications du diabète

Collaborateurs

Voir plus
Renard Eric
Renard Eric
Hôpital Lapeyronie, Montpellier, France
Schaepelynck-Belicar Pauline
Schaepelynck-Belicar Pauline
Hôpital Sainte Marguerite, Marseille, France
Franc Sylvia
Franc Sylvia
Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France
Benhamou Pierre-Yves
Benhamou Pierre-Yves
Hôpital Nord Grenoble, La Tronche, France

Industries

Voir plus
M3 Global Research Ltd
58 collaboration(s)
Dernière en 2023
B3TSI
49 collaboration(s)
Dernière en 2023
A+A
28 collaboration(s)
Dernière en 2023
PASCALEO
14 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Safety and Efficacy of Sustained Automated Insulin Delivery Compared With Sensor and Pump Therapy in Adults With Type 1 Diabetes at High Risk for Hypoglycemia: A Randomized Controlled Trial.
Diabetes care   20 septembre 2023
Hybrid Closed Loop Overcomes the Impact of Missed or Suboptimal Meal Boluses on Glucose Control in Children with Type 1 Diabetes Compared to Sensor-Augmented Pump Therapy.
Diabetes technology & therapeutics   06 avril 2023
FREELIFE-KID: Assessment of the Efficacy of Closed-loop Insulin Therapy (Artificial Pancreas) on the Control of Type 1 Diabetes in Prepubertal Child in Free-life: Comparison Between Nocturnal and 24-hour Use on 18 Weeks, Followed by an Extension on 18 Weeks
Essai Clinique (CHU Montpellier)   15 décembre 2021
Outcomes of hybrid closed-loop insulin delivery activated 24/7 versus evening and night in free-living prepubertal children with type 1 diabetes: A multicentre, randomized clinical trial.
Diabetes, obesity & metabolism   01 décembre 2021
Practical implementation of automated closed-loop insulin delivery: A French position statement.
Diabetes & metabolism   02 novembre 2020
Alarmes de seuil de glucose des dispositifs de surveillance du glucose interstitiel : consensus sur leurs avantages et inconvénients à travers un panel Delphi
Médecine des Maladies Métaboliques   01 novembre 2020
DIABEO System Combining a Mobile App Software With and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetes Patients Poorly Controlled with a Basal-Bolus Insulin Regimen.
Diabetes technology & therapeutics   14 octobre 2020
Mise en place de l’insulinothérapie automatisée en boucle fermée : position d’experts français
Médecine des Maladies Métaboliques   01 septembre 2020
Closed-loop insulin therapy in free-life shows better glucose control when used 24/7 versus overnight only in pre-pubertal children with type 1 diabetes: interim analysis of the Free-life Kid AP Study
Abstracts for the 45th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes (ISPAD), October 30–November 2, 2019, Boston, USA   29 octobre 2019
Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial.
The Lancet. Digital health   02 mai 2019